Inquire Before Buying - India Preclinical Research Market Size and Report 2025-2030

India Preclinical Research Market Report: Forecast (2025-2030)

India Preclinical Research Market Report - By Model Type (Patient-Derived Organoid (PDO) model, Patient-Derived Xenograft (PDX) model), By Service (Bioanalysis and DMPK studies, [I......n vitro ADME, In-vivo PK], Toxicology testing, [GLP, Non-GLP], Compound management, [Process R&D, Custom synthesis, Others], Chemistry, [Medicinal chemistry, Computation chemistry], Safety Pharmacology Others), By End User (Biopharmaceutical Companies, Government and academic institutes, Medical device companies, Others), and Others Read more

Healthcare
Nov 2024
Pages 123
Report Format: PDF, Excel, PPT

Market Definition

Preclinical research is the field that investigates a possible medication and tests it to find cures before the drug is used on humans. It entails experiments and other studies to determine the cause of illness by testing possible treatments on animals.

Market Insights & Analysis: India Preclinical Research Market (2025-2030):

The India Preclinical Research Market size was valued at around USD 175 million in 2024 and is projected to reach USD 300 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 11.5% during the forecast period (2025-30). The market growth is ascribed to several factors including the sizeable patient base, rising demand for innovative drug development, encouraging government policies, low trial costs, and growing outsourcing trends of clinical trials in the R&D domain globally.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 175 Million
Market Value By 2030	USD 300 Million
CAGR (2025-30)	11.5%
Leading Region	South region
Top Key Players	Syngene International Limited, Dabur Research, JSS Medical Research, Jubilant Biosys Ltd., Sugen Life Sciences, Eurofins Advinus, GVRP, Veeda Clinical Research Limited, Axis Clinicals, Syneos Health, Ethicare-cro, Liveon Biolabs Pvt. Ltd., IQVIA Inc., Bioneeds, TheraIndx Lifesciences Pvt. Ltd., Abiogenesis Clinpharm, Accutest Global, Asiatic Clinical Research, Bio Reliance Corporation, Cliniminds, Hi Tech Bio Laboratories, GVK Biosciences, and others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, due to the large number of patients suffering from autoimmune, immunology, cardiovascular, infectious, oncology, & respiratory diseases and central nervous system (CNS) disorders in India, the requirement for preclinical research and testing has grown drastically. Continuous preclinical research and trials are being conducted to develop drugs to cure millions of patients. For instance; In October 2023, NexCAR19 was approved by the Central Drugs Standard Control Organization (CDSCO) as India's first CAR-T cell therapy based on two small clinical trials that involved 64 people with advanced lymphoma or leukemia. Between 2023-24 more than 40 new drugs were approved by CDSCO for the cures of multiple diseases in India. Moreover, In March 2024, 229 new medical devices were approved after preclinical trials.

In India, phase two and phase three clinical trials, have grown from 15% to 18% just between the period 2017-23. Preclinical trials in India have become more accessible and accelerated due to the global increase in outsourcing trends in the R&D of preclinical trials. From 2012-22, approximately 49,269 clinical trials occurred in India and have been growing since then. Multinational pharmaceutical companies seeking to optimize their R&D expenditures, find India as a desirable option due to its affordable and high-quality preclinical research services as compared to other markets in the US and Europe. India also offers high-class research facilities and equipment with innovative research techniques available at low operational cost enhancing its competitiveness in the global market.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
India Preclinical Research Market Trends & Deployments
India Preclinical Research Market Dynamics
1. Growth Drivers
2. Challenges
India Preclinical Research Market Opportunities & Hotspots
India Preclinical Research Market Value Chain Analysis
India Preclinical Research Market Regulations and Policy
India Preclinical Research Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Model Type
    1. Patient-Derived Organoid (PDO) model- Market Size & Forecast 2020-2030, USD Million
    2. Patient-Derived Xenograft (PDX) model- Market Size & Forecast 2020-2030, USD Million
  2. By Service
    1. Bioanalysis and DMPK studies- Market Size & Forecast 2020-2030, USD Million
      1. In vitro ADME- Market Size & Forecast 2020-2030, USD Million
      2. In-vivo PK- Market Size & Forecast 2020-2030, USD Million
    2. Toxicology testing- Market Size & Forecast 2020-2030, USD Million
      1. GLP- Market Size & Forecast 2020-2030, USD Million
      2. Non-GLP- Market Size & Forecast 2020-2030, USD Million
    3. Compound management- Market Size & Forecast 2020-2030, USD Million
      1. Process R&D- Market Size & Forecast 2020-2030, USD Million
      2. Custom synthesis- Market Size & Forecast 2020-2030, USD Million
      3. Others- Market Size & Forecast 2020-2030, USD Million
    4. Chemistry- Market Size & Forecast 2020-2030, USD Million
      1. Medicinal chemistry- Market Size & Forecast 2020-2030, USD Million
      2. Computation chemistry- Market Size & Forecast 2020-2030, USD Million
    5. Safety Pharmacology-Market Size & Forecast 2020-2030, USD Million
    6. Others- Market Size & Forecast 2020-2030, USD Million
  3. By End User
    1. Biopharmaceutical Companies- Market Size & Forecast 2020-2030, USD Million
    2. Government and academic institutes- Market Size & Forecast 2020-2030, USD Million
    3. Medical device companies- Market Size & Forecast 2020-2030, USD Million
    4. Others- Market Size & Forecast 2020-2030, USD Million
  4. By Region
    1. North
    2. East
    3. West
    4. South
  5. By Company
    1. Competition Characteristics
    2. Market Share and Analysis
North India Preclinical Research Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Model Type- Market Size & Forecast 2020-2030, USD Million
  2. By Service-Market Size & Forecast 2020-2030, USD Million
  3. By End User- Market Size & Forecast 2020-2030, USD Million
South India Preclinical Research Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Model Type- Market Size & Forecast 2020-2030, USD Million
  2. By Service-Market Size & Forecast 2020-2030, USD Million
  3. By End User- Market Size & Forecast 2020-2030, USD Million
West India Preclinical Research Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Model Type- Market Size & Forecast 2020-2030, USD Million
  2. By Service-Market Size & Forecast 2020-2030, USD Million
  3. By End User- Market Size & Forecast 2020-2030, USD Million
East India Preclinical Research Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Model Type- Market Size & Forecast 2020-2030, USD Million
  2. By Service-Market Size & Forecast 2020-2030, USD Million
  3. By End User- Market Size & Forecast 2020-2030, USD Million
India Preclinical Research Market Strategic Imperatives for Growth & Success
Competition Outlook
1. Company Profiles
  1. Syngene International Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  2. Dabur Research
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  3. JSS Medical Research
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  4. Jubilant Biosys Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  5. Sugen Life Sciences
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  6. Eurofins Advinus
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  7. GVRP
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  8. Veeda Clinical Research Limited
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  9. Axis Clinicals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  10. Syneos Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  11. Ethicare-cro
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  12. Liveon Biolabs Pvt. Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  13. IQVIA Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  14. Bioneeds
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  15. TheraIndx Lifesciences Pvt. Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  16. Abiogenesis Clinpharm
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  17. Accutest Global
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  18. Asiatic Clinical Research
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  19. Bio Reliance Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  20. Cliniminds
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  21. Hi Tech Bio Laboratories
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  22. GVK Biosciences
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Deployments
    5. Financial Details
    6. Others
  23. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *